🟡 Johnson & Johnson (JNJ). Report on July 16 before opening. After 2021, the company’s growth slowed significantly. Over the past four years, the stock has been trading in the $140–$180 range. Currently, prices are closer to the lower end of the range, so you can try a mid-term position.
🔴 Netflix (NFLX). Report on July 17 after closing. Morgan Stanley analysts predict that AI will take Netflix’s advanced recommendation system “to the next level” and user engagement will grow above the current two hours per day. Netflix can also use AI to offer advertisers “the best of branded advertising with targeting and attribution.” Wells Fargo sees Netflix accelerating to double digits revenue growth with margin expansion and a nice free cash ramp ahead.
⚠️ For fans of expensive volatile stocks. Use leverage up to X100 on the UTEX to participate in the NFLX movement on the report. A gap in either direction is possible.
🟡 PepsiCo (PEP). Report on July 17 before the opening. Down 16% for the year, while its main competitor, Coca-Cola, is up 11%. Since May 2023, PEP’s steady growth has stopped, and the stock is quite far from its highs. Prices are already quite attractive, but this is more of a long-term opportunity.
🔴 Cintas (CTAS). Report on July 17 before opening. Supplier of corporate uniforms and related services. Since 2012, the stock has grown steadily from $8 to $228 during this time. In December 2024, the first significant pullback occurred (excluding the decline during the pandemic). The stock is already approaching its highs. On July 1, Wells Fargo upgraded the company’s rating to “Outperform.” Analysts noted the company’s excellent infrastructure. In their opinion, Cintas will increase its market share by taking it from its competitors. There was a gap at the last two reports. Historical highs are not far off, so there could be strong movements in either direction. Especially if the figures in the report diverge from analysts’ expectations.
🔴 Elevance Health (ELV). Report on July 17 before the opening. Health insurance has never been a glamorous and fast-growing business, but it has offered stable profits, backed by the expansion of government programs. But stocks in the sector — UnitedHealth Group (UNH), Humana (HUM), Molina Healthcare (MOH) — have fallen by 30–40% over the past year. There seem to be serious flaws in the model itself: health insurance companies are caught between rising costs and a lack of funding. The sell-off may continue.
Trade what suits you best:
🔴 high risk, for the pros;
🟡 medium risk, for traders with little experience.
All tickers are already in the Hot on Bybit Exchange
Profitable trades!
